litlas
ログインアカウント作成

Joan H. Schiller

1991–2025 年に発表

97
論文数
37,501
被引用数
83
h 指数
96
i10 指数

被引用数

Joan H. Schiller の年別被引用数1993 年: 被引用 3 件1994 年: 被引用 2 件1995 年: 被引用 5 件1996 年: 被引用 6 件1997 年: 被引用 8 件1998 年: 被引用 7 件1999 年: 被引用 8 件2000 年: 被引用 10 件2001 年: 被引用 19 件2002 年: 被引用 48 件2003 年: 被引用 79 件2004 年: 被引用 173 件2005 年: 被引用 326 件2006 年: 被引用 301 件2007 年: 被引用 317 件2008 年: 被引用 304 件2009 年: 被引用 430 件2010 年: 被引用 437 件2011 年: 被引用 406 件2012 年: 被引用 382 件2013 年: 被引用 377 件2014 年: 被引用 271 件2015 年: 被引用 302 件2016 年: 被引用 321 件2017 年: 被引用 264 件2018 年: 被引用 272 件2019 年: 被引用 856 件2020 年: 被引用 809 件2021 年: 被引用 737 件2022 年: 被引用 522 件2023 年: 被引用 345 件2024 年: 被引用 532 件2025 年: 被引用 197 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,180 件、この内訳の 27.3%中国: 引用元論文 1,367 件、この内訳の 11.8%日本: 引用元論文 637 件、この内訳の 5.5%イギリス: 引用元論文 577 件、この内訳の 5%イタリア: 引用元論文 550 件、この内訳の 4.7%ドイツ: 引用元論文 467 件、この内訳の 4%カナダ: 引用元論文 454 件、この内訳の 3.9%フランス: 引用元論文 424 件、この内訳の 3.6%スペイン: 引用元論文 382 件、この内訳の 3.3%韓国: 引用元論文 302 件、この内訳の 2.6%オランダ: 引用元論文 293 件、この内訳の 2.5%オーストラリア: 引用元論文 271 件、この内訳の 2.3%
0%27.3%その他 23.5%

機関

分野

  • Medicine70.2%
  • Biochemistry, Genetics and Molecular Biology21.2%
  • Immunology and Microbiology2.6%
  • Computer Science0.7%
  • Chemistry0.7%
  • Materials Science0.7%
  • その他3.9%

トピック

  • Lung Cancer Treatments and Mutations14.7%
  • Lung Cancer Research Studies7.1%
  • Lung Cancer Diagnosis and Treatment6.4%
  • Cancer Immunotherapy and Biomarkers4.2%
  • Cancer Genomics and Diagnostics3.2%
  • HER2/EGFR in Cancer Research2.3%
  • その他62.1%

共著者

全論文

検索で開く
  1. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    著者: Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn - JAMA 2014 被引用: 1,744

  2. Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

    著者: Alan Sandler, Robert J. Gray, Michael C. Perry, Julie R. Brahmer, Joan H. Schiller, Afshin Dowlati, Rogério Lilenbaum, David H. Johnson - New England Journal of Medicine 2006 被引用: 5,778

  3. Lung cancer in never smokers — a different disease

    著者: Sophie Sun, Joan H. Schiller, Adi F. Gazdar - Nature reviews. Cancer 2007 被引用: 1,602

  4. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    著者: Nasser H. Hanna, Bryan J. Schneider, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H. Johnson, Natasha B. Leighl, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Navneet Singh, David R. Spigel, Janis O. Stabler, Joan Tashbar, Gregory A. Masters - Journal of Clinical Oncology 2020 被引用: 455

  5. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

    著者: Joan H. Schiller, David Harrington, Chandra P. Belani, Corey J. Langer, Alan Sandler, James E. Krook, Junming Zhu, David H. Johnson - New England Journal of Medicine 2002 被引用: 4,984

  6. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    著者: Nasser H. Hanna, Andrew Robinson, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H. Johnson, Natasha B. Leighl, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, Navneet Singh, David R. Spigel, Joan Tashbar, Gregory A. Masters - Journal of Clinical Oncology 2021 被引用: 301

  7. Air Pollution and Lung Cancer: A Review by International Association for the Study of Lung Cancer Early Detection and Screening Committee

    著者: Christine D. Berg, Joan H. Schiller, Paolo Boffetta, Jing Cai, Casey Connolly, Anna Kerpel-Fronius, Andrea Borondy Kitts, David Lam, Anant Mohan, Renelle Myers, Tejas Menon Suri, Martin C. Tammemägi, Dawei Yang, Stephen Lam - Journal of Thoracic Oncology 2023 被引用: 162

  8. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

    著者: Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi - Journal of Clinical Oncology 2022 被引用: 124

  9. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

    著者: Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi - Journal of Clinical Oncology 2022 被引用: 113

  10. Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

    著者: Joachim von Pawel, Joan H. Schiller, Frances A. Shepherd, Scott Z. Fields, J P Kleisbauer, Nick G. Chrysson, David J. Stewart, Peter Clark, Martin Palmer, A Depierre, James Carmichael, Jacqueline B. Krebs, Graham Ross, Stephen Lane, Richard J. Gralla - Journal of Clinical Oncology 1999 被引用: 960

  11. A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

    著者: Hao Tang, Guanghua Xiao, Carmen Behrens, Joan H. Schiller, Jeffrey A. Allen, Chi‐Wan Chow, Milind Suraokar, Alejandro H. Corvalán, Jian‐Hua Mao, Michael A. White, Ignacio I. Wistuba, John D. Minna, Yang Xie - Clinical Cancer Research 2013 被引用: 291

  12. A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

    著者: Alberto Chiappori, Tatjana Kolevska, David R. Spigel, Steven Hager, Mark U. Rarick, Shirish M. Gadgeel, Normand Blais, Joachim von Pawel, L. Hart, Martin Reck, Ekaterina Bassett, Bart Burington, Joan H. Schiller - Annals of Oncology 2014 被引用: 178

  13. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    著者: Nasser H. Hanna, David H. Johnson, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiyesimi, Natasha B. Leighl, Gregory J. Riely, Joan H. Schiller, Bryan J. Schneider, Thomas J. Smith, Joan Tashbar, William A. Biermann, Gregory A. Masters - Journal of Clinical Oncology 2017 被引用: 650

  14. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    著者: Gregory A. Masters, Sarah Temin, Christopher G. Azzoli, Giuseppe Giaccone, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Ajeet Gajra, Nancy Rackear, Joan H. Schiller, Thomas J. Smith, John R. Strawn, David Trent, David H. Johnson - Journal of Clinical Oncology 2015 被引用: 851

  15. Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer

    著者: David E. Gerber, Jeffrey R. Infante, Michael S. Gordon, Sarah B. Goldberg, Miguel Martín, Enriqueta Felip, Maria Martinez‐García, Joan H. Schiller, David R. Spigel, Julie Cordova, Valerie Westcott, Yulei Wang, David S. Shames, YounJeong Choi, Robert S. Kahn, Randall Dere, Divya Samineni, Jian Xu, Kedan Lin, Katie Wood, Stephanie Royer‐Joo, Vanessa Lemahieu, Eva Schuth, Anjali Vaze, Daniel Maslyar, Eric W. Humke, Howard A. Burris - Clinical Cancer Research 2019 被引用: 53

  16. Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations

    著者: Adi Gazdar, Linda Robinson, Dwight Oliver, Chao Xing, William D. Travis, Junichi Soh, Shinichi Toyooka, Lori Watumull, Yang Xie, Kemp H. Kernstine, Joan H. Schiller - Journal of Thoracic Oncology 2014 被引用: 153

  17. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

    著者: Mark G. Kris, Ronald B. Natale, Roy S. Herbst, T. J. Lynch, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, H. Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael Wolf, Steven D. Averbuch, Judith Ochs, Andrea Kay - JAMA 2003 被引用: 2,538

  18. Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

    著者: Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio V. Scagliotti, Rafael Rosell, Vincent A. Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, A Płużańska, U. Gatzemeier, John Grous, Judith Ochs, Steven D. Averbuch, Michael Wolf, Pamela Rennie, Abderrahim Fandi, David H. Johnson - Journal of Clinical Oncology 2004 被引用: 1,720

  19. Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

    著者: Andrea Ardizzoni, Luca Boni, Marcello Tiseo, Frank V. Fossella, Joan H. Schiller, Marianne Paesmans, Davorin Radosavljević, Adriano Paccagnella, Petr Zatloukal, Paola Mazzanti, D. Bisset, R. Rosell - JNCI Journal of the National Cancer Institute 2007 被引用: 608

  20. Stigma among patients with lung cancer: a patient-reported measurement model

    著者: Heidi Hamann, Jamie S. Ostroff, Emily Marks, David E. Gerber, Joan H. Schiller, Simon J. Craddock Lee - Psycho-Oncology 2013 被引用: 169

  21. Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

    著者: Suzanne E. Dahlberg, Joan H. Schiller, Philip Bonomi, Alan B. Sandler, Julie R. Brahmer, Suresh S. Ramalingam, David H. Johnson - Journal of Thoracic Oncology 2013 被引用: 110

  22. The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations—The Lung Cancer Mutation Consortium (LCMC2)

    著者: Dara L. Aisner, Lynette M. Sholl, Lynne D. Berry, Michael R. Rossi, Heidi Chen, Junya Fujimoto, André L. Moreira, Suresh S. Ramalingam, Liza C. Villaruz, Gregory A. Otterson, Eric B. Haura, Katerina Politi, Bonnie S. Glisson, Jeremy Cetnar, Edward B. Garon, Joan H. Schiller, Saiama N. Waqar, Lecia V. Sequist, Julie R. Brahmer, Yu Shyr, Kelly Kugler, Ignacio I. Wistuba, Bruce E. Johnson, John D. Minna, Mark G. Kris, Paul A. Bunn, David J. Kwiatkowski - Clinical Cancer Research 2017 被引用: 218

  23. Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies

    著者: Hao Tang, Sophia Mei Wang, G. Xiao, Joan H. Schiller, Vassiliki A. Papadimitrakopoulou, J D Minna, Ignacio I. Wistuba, Yang Xie - Annals of Oncology 2017 被引用: 108

  24. Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)

    著者: Jyoti D. Patel, Ju-Whei Lee, David P. Carbone, Henry Wagner, Anil Shanker, Maria Teresa P. de Aquino, Leora Horn, Melissa L. Johnson, David E. Gerber, Jane Jijun Liu, Millie Das, Mohammed Ali Al-Nsour, Christopher Dakhil, Suresh S. Ramalingam, Joan H. Schiller - Clinical Lung Cancer 2020 被引用: 23